Skip links

Increasing the Velocity of Digital Transformation

Jump To Section

A leading global financial institution used Altimetrik’s domain-driven design model to turn a rigid, monolithic platform approach into one that’s driven by API and microservices.

A modern microservices architecture speeds up time-to-market and improves customer service.

A leading global financial institution used Altimetrik’s domain-driven design model to turn a rigid, monolithic platform approach into one that’s driven by API and microservices. The result was an extremely scalable, multi-channel platform with far greater development, integration flexibility, and faster time to market for future product and service launches.

Additionally, engineering processes were transformed with the selection and integration of new DevOps and Cloud capabilities.

  • 5x Improved Platform Performance and Scalability
  • 44% Increase in Delivery Velocity
  • 40% Increase in Sprint Success Rate
  • 85% Reduction in Release Cycle Time

Core digital platforms transform from rigid and monolithic to scalable and custom.

Altimetrik followed a domain-driven design (DDD) model to transition to an API-driven, microservices-based architecture. This gave our financial services client an extremely scalable, multi-channel platform with far greater development and integration flexibility. Additionally, new offerings could be launched on the platform in a much shorter time.

This DDD approach allowed us to foster a close working relationship with business stakeholders, gain a comprehensive understanding of their needs, and effectively deconstruct complex business functions.

Altimetrik also transformed the client’s engineering process from a mini-waterfall SDLC process to a DevOps-enabled process by:

  • Consolidating the toolchain and standardizing the branching model
  • Implementing a common versioning model from development to production
  • Developing pipeline and infrastructure as code for CI/CD
  • Implementing pipeline definitions to manage multi-data-center deployments
  • Automating security, functional, and integration tests
  • Enabling autonomous development teams

Starting with four scrum teams, the engagement quickly expanded to include over 40 teams with 18 different areas of expertise in three locations, demonstrating Altimetrik’s ability to quickly scale to meet the demands of a complex and distributed engagement.

“We are helping a large financial institution increase resilience and improve scalability, speed to market, and ROI by leveraging our expertise in domain-driven design.”

Mohammed Farooqui

East Business Head

admin

admin

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes